PAR. SP, page-1009

Some people need to go away and look at the speed of FDA decison making in its various processes - its well covered. This is not an investment for the impatient. It is relatively bargain investment levels for the new patient investors and a continued flogging for longer-term holders in the context of the share price history.

FOMO is such an overlooked destroyer of value in investing:



For years PR and co. have encouraged FOMO (and others on these threads, many long gone) with ambiguous pump. The waiting partnerships have at last now been described in quite specific detail on various media forums now. Its just a waiting game for the FDA. A share price spike likely on affirmation on ensuing partnerships, or a slow burn to zero if not.

Its called playing the pot odds in poker. The pot odds in this case vastly outweigh the odds of a failed hand. The FDA will soon reveal its cards to the patient.